Braidwell LP
- SEC CIK
- 0001920938
- Latest filing
- Aug 14, 2026
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 14, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 81
- 0 vs. Q1 2023
- Portfolio value
- $3.06B
- +$28.4M (+0.9%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ATECAlphatec Holdings, Inc. | COM NEW | 25,431 | $457.2K | <0.1% | +25,431 | New | History |
| ESPREsperion Therapeutics, Inc. | COM | 895,949 | $1.25M | <0.1% | −315,570−26.0% | Reduced | History |
| INSMED Inc457669AB5 | NOTE 0.750% 6/0 | – | $2.95M | 0.1% | – | – | – |
| ADPTAdaptive Biotechnologies Corp | COM | 648,451 | $4.35M | 0.1% | 00.0% | Unchanged | History |
| Cutera Inc232109AD0 | NOTE 2.250% 6/0 | – | $7.20M | 0.2% | – | New | – |
| NUVBNuvation Bio Inc. | COM CL A | 4,122,900 | $7.42M | 0.2% | 00.0% | Unchanged | History |
| AGENAgenus Inc | COM NEW | 4,697,930 | $7.52M | 0.2% | +4,697,930 | New | History |
| SGENSeagen Inc. | COM | 42,497 | $8.18M | 0.3% | +42,497 | New | History |
| MRTXMirati Therapeutics, Inc. | COM | 240,625 | $8.69M | 0.3% | −211,375−46.8% | Reduced | History |
| MLYSMineralys Therapeutics, Inc. | COM | 550,300 | $9.38M | 0.3% | 00.0% | Unchanged | History |
| ALXOAlx Oncology Holdings Inc | COM | 1,249,900 | $9.39M | 0.3% | 00.0% | Unchanged | History |
| GHGuardant Health, Inc. | COM | 270,000 | $9.67M | 0.3% | +270,000 | New | History |
| SLRNACELYRIN, Inc. | COM | 500,000 | $10.4M | 0.3% | +500,000 | New | History |
| REPLReplimune Group, Inc. | COM | 487,520 | $11.3M | 0.4% | +413,855+561.8% | Added | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 650,312 | $11.7M | 0.4% | −1,369,402−67.8% | Reduced | History |
| RGENRepligen Corp | COM | 92,000 | $13.0M | 0.4% | +92,000 | New | History |
| LUNGPulmonx Corp | COM | 999,362 | $13.1M | 0.4% | −163,932−14.1% | Reduced | History |
| DHRDanaher Corp | Stock | 55,400 | $13.3M | 0.4% | +55,400 | New | History |
| Integra Lifesciences Hldgs C457985AM1 | NOTE 0.500% 8/1 | – | $13.3M | 0.4% | – | New | – |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 843,087 | $13.9M | 0.5% | +843,087 | New | History |
| TMOThermo Fisher Scientific Inc. | Stock | 27,300 | $14.2M | 0.5% | +27,300 | New | History |
| Invitae Corp46185LAB9 | NOTE 2.000% 9/0 | – | $15.0M | 0.5% | – | – | – |
| DYNDyne Therapeutics, Inc. | COM | 1,377,872 | $15.5M | 0.5% | 00.0% | Unchanged | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 1,842,352 | $16.1M | 0.5% | −154,703−7.7% | Reduced | History |
| VIRVir Biotechnology, Inc. | COM | 728,549 | $17.9M | 0.6% | +124,513+20.6% | Added | History |
| RAPTRAPT Therapeutics, Inc. | COM | 984,400 | $18.4M | 0.6% | +984,400 | New | History |
| CMPXCompass Therapeutics, Inc. | COM | 5,954,273 | $18.9M | 0.6% | +2,706,426+83.3% | Added | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 2,791,880 | $19.7M | 0.6% | +846,746+43.5% | Added | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,908,865 | $20.5M | 0.7% | +1,908,865 | New | History |
| HLVXHilleVax, Inc. | COM | 1,249,246 | $21.5M | 0.7% | −370,970−22.9% | Reduced | History |
| ENTAEnanta Pharmaceuticals Inc | COM | 1,038,310 | $22.2M | 0.7% | 00.0% | Unchanged | History |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 1,804,700 | $22.4M | 0.7% | +1,804,700 | New | History |
| Illumina, Inc.452327AK5 | NOTE 8/1 | – | $22.6M | 0.7% | – | – | – |
| PENPenumbra Inc | COM | 65,844 | $22.7M | 0.7% | −41,200−38.5% | Reduced | History |
| Travere Therapeutics, Inc.89422GAA5 | NOTE 2.250% 3/0 | – | $22.8M | 0.7% | – | – | – |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 12,107,785 | $23.0M | 0.8% | 00.0% | Unchanged | History |
| ANABAnaptysbio, Inc | COM | 1,154,423 | $23.5M | 0.8% | +181,350+18.6% | Added | History |
| ALECAlector, Inc. | COM | 4,131,315 | $24.8M | 0.8% | +925,000+28.8% | Added | History |
| Amyris, Inc.03236MAJ0 | NOTE 1.500%11/1 | – | $26.2M | 0.9% | – | – | – |
| Neogenomics Inc64049MAA8 | NOTE 1.250% 5/0 | – | $26.3M | 0.9% | – | – | – |
| HROWHarrow, Inc. | COM | 1,452,538 | $27.7M | 0.9% | 00.0% | Unchanged | History |
| IMCRImmunocore Holdings plc | ADS | 468,027 | $28.1M | 0.9% | +41,917+9.8% | Added | History |
| KRYSKrystal Biotech, Inc. | COM | 241,399 | $28.3M | 0.9% | −106,637−30.6% | Reduced | History |
| VRDNViridian Therapeutics, Inc. | COM | 1,206,300 | $28.7M | 0.9% | +1,206,300 | New | History |
| AXNXAxonics, Inc. | COM | 573,791 | $29.0M | 0.9% | +407,087+244.2% | Added | History |
| ACRSAclaris Therapeutics, Inc. | COM | 2,901,194 | $30.1M | 1.0% | −367,900−11.3% | Reduced | History |
| OMOutset Medical, Inc. | COM | 1,460,368 | $31.9M | 1.0% | −293,982−16.8% | Reduced | History |
| KIDSOrthopediatrics Corp | COM | 761,208 | $33.4M | 1.1% | −237,663−23.8% | Reduced | History |
| BIIBBiogen Inc. | COM | 121,942 | $34.7M | 1.1% | −98,800−44.8% | Reduced | History |
| Neogenomics Inc64049MAB6 | NOTE 0.250% 1/1 | – | $36.1M | 1.2% | – | – | – |
| FNAParagon 28, Inc. | COM | 2,136,122 | $37.9M | 1.2% | +1,037,400+94.4% | Added | History |
| INSMED Inc457669AA7 | NOTE 1.750% 1/1 | – | $38.0M | 1.2% | – | – | – |
| LEGNLegend Biotech Corp | SPONSORED ADS | 556,301 | $38.4M | 1.3% | −45,500−7.6% | Reduced | History |
| BridgeBio Pharma, Inc.10806XAD4 | NOTE 2.250% 2/0 | – | $38.6M | 1.3% | – | – | – |
| BSXBoston Scientific Corp | Stock | 717,050 | $38.8M | 1.3% | +717,050 | New | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 3,361,813 | $40.1M | 1.3% | +201,918+6.4% | Added | History |
| MRUSMerus N.V. | COM | 1,543,162 | $40.6M | 1.3% | +70,078+4.8% | Added | History |
| ISRGIntuitive Surgical Inc | COM NEW | 123,820 | $42.3M | 1.4% | −99,300−44.5% | Reduced | History |
| Karyopharm Therapeutics Inc.48576UAA4 | NOTE 3.000%10/1 | – | $43.0M | 1.4% | – | – | – |
| NVRONevro Corp | COM | 1,776,368 | $45.2M | 1.5% | +143,453+8.8% | Added | History |
| KROSKeros Therapeutics, Inc. | COM | 1,143,865 | $46.0M | 1.5% | +1,143,865 | New | History |
| DICEDICE Therapeutics, Inc. | COM | 1,029,901 | $47.8M | 1.6% | +45,101+4.6% | Added | History |
| IRTCiRhythm Holdings, Inc. | COM | 478,557 | $49.9M | 1.6% | +24,388+5.4% | Added | History |
| Ionis Pharmaceuticals Inc462222AD2 | NOTE 4/0 | – | $50.0M | 1.6% | – | – | – |
| Nuvasive Inc670704AJ4 | NOTE 0.375% 3/1 | – | $50.1M | 1.6% | – | – | – |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $50.5M | 1.7% | – | – | – |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 3,646,419 | $51.3M | 1.7% | +405,068+12.5% | Added | History |
| NTRANatera, Inc. | COM | 1,152,851 | $56.1M | 1.8% | +170,610+17.4% | Added | History |
| XENEXenon Pharmaceuticals Inc. | COM | 1,828,353 | $70.4M | 2.3% | −308,757−14.4% | Reduced | History |
| GKOSGLAUKOS Corp | COM | 1,044,392 | $74.4M | 2.4% | −762,259−42.2% | Reduced | History |
| ALGNAlign Technology Inc | COM | 224,030 | $79.2M | 2.6% | +16,900+8.2% | Added | History |
| Alphatec Hldgs Inc02081GAB8 | NOTE 0.750% 8/0 | – | $82.4M | 2.7% | – | – | – |
| PCVXVaxcyte, Inc. | COM | 1,722,353 | $86.0M | 2.8% | +402,375+30.5% | Added | History |
| NBIXNeurocrine Biosciences Inc | Stock | 933,362 | $88.0M | 2.9% | +166,562+21.7% | Added | History |
| Nevro Corp64157FAC7 | NOTE 2.750% 4/0 | – | $100.9M | 3.3% | – | – | – |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $101.1M | 3.3% | – | – | – |
| Ascendis Pharma A/S04351PAD3 | NOTE 2.250% 4/0 | – | $113.2M | 3.7% | – | New | – |
| Nanostring Technologies Inc63009RAD1 | NOTE 2.625% 5/0 | – | $115.4M | 3.8% | – | – | – |
| NovoCure Ltd67011XAB9 | NOTE 11/0 | – | $118.2M | 3.9% | – | – | – |
| Exact Sciences Corp30063PAC9 | NOTE 0.375% 3/0 | – | $134.7M | 4.4% | – | – | – |
| Guardant Health, Inc.40131MAB5 | NOTE 11/1 | – | $193.1M | 6.3% | – | – | – |
Sold out since Q1 2023 (18)
Positions held at the end of Q1 2023 that are gone from this filing.
| Security | Class | Shares in Q1 2023 | Value in Q1 2023 | % of portfolio in Q1 2023 | History |
|---|---|---|---|---|---|
| ISEEIVERIC bio, Inc. | COM | 3,714,672 | $90.4M | 3.0% | History |
| Nuvasive Inc670704AL9 | NOTE 1.000% 6/0 | – | $51.1M | 1.7% | – |
| Exact Sciences Corp30063PAB1 | NOTE 0.375% 3/1 | – | $45.2M | 1.5% | – |
| AMGNAmgen Inc | Stock | 161,500 | $39.0M | 1.3% | History |
| Ionis Pharmaceuticals Inc462222AB6 | NOTE 0.125%12/1 | – | $33.8M | 1.1% | – |
| Bellus Health Inc New07987C204 | COM NEW | 4,126,194 | $29.7M | 1.0% | – |
| SNDXSyndax Pharmaceuticals Inc | COM | 920,049 | $19.4M | 0.6% | History |
| GMEDGlobus Medical Inc | Stock | 335,200 | $19.0M | 0.6% | History |
| STESTERIS plc | SHS USD | 95,694 | $18.3M | 0.6% | History |
| MRSNMersana Therapeutics, Inc. | COM | 3,355,805 | $13.8M | 0.5% | History |
| PACBPacific Biosciences of California, Inc. | COM | 1,097,300 | $12.7M | 0.4% | History |
| ACLXArcellx, Inc. | COMMON STOCK | 333,800 | $10.3M | 0.3% | History |
| ARGXArgenx SE | SPONSORED ADR | 24,600 | $9.17M | 0.3% | History |
| TMDXTransMedics Group, Inc. | COM | 98,459 | $7.46M | 0.2% | History |
| Supernus Pharmaceuticals, Inc.868459AD0 | NOTE 0.625% 4/0 | – | $6.52M | 0.2% | – |
| SILKSilk Road Medical Inc | COM | 63,331 | $2.48M | 0.1% | History |
| IMTXImmatics N.V. | SHS | 322,287 | $2.22M | 0.1% | History |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 247,254 | $432.7K | <0.1% | History |